The HORIBA Medical Segment designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in vitro diagnostics is one of the most respected in hematology worldwide and contribute today to the health of tomorrow.

Key indicators

  • Over 1,100 employees
  • 5 production centers (Japan, China, France, Brazil, India)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 14 local/direct operations
  • Around 30,000 laboratories supplied worldwide

16 Jan 2017 - We are pleased to announce our participation to the MEDLAB fair that will attend in Dubaï from the...

Read more